(TEVA) Teva Pharma Industries - Performance 1.1% in 12m
TEVA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
21.82%
#48 in Peer-Group
Rel. Strength
38.82%
#4711 in Stock-Universe
Total Return 12m
1.13%
#84 in Peer-Group
Total Return 5y
47.66%
#34 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 6.56 |
| High / Low | USD |
|---|---|
| 52 Week High | 22.77 USD |
| 52 Week Low | 12.82 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 38.40 |
| Buy/Sell Signal +-5 | -0.71 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: TEVA (1.1%) vs XLV (-3.8%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
3.97% | 137% | 332% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
5.14% | 18.3% | 78.4% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
3.98% | -12.5% | 396% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NOVN SW Novartis |
1.57% | 4.32% | 49.4% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-5.64% | 3.65% | 46.3% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-3.33% | -5.85% | 108% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-3.3% | -7.74% | 44% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
-1.26% | -7.68% | 38.7% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: TEVA vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for TEVA
| Total Return (including Dividends) | TEVA | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -1.05% | 2.34% | 5.22% |
| 3 Months | 14.55% | -4.88% | 16.86% |
| 12 Months | 1.13% | -3.83% | 14.81% |
| 5 Years | 47.66% | 42.89% | 111.83% |
| Trend Score (consistency of price movement) | TEVA | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -73.1% | 35.8% | 81% |
| 3 Months | 67.3% | -28.5% | 96.9% |
| 12 Months | -34.1% | -74.5% | 44.9% |
| 5 Years | 50% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th43.00 | -3.31% | -5.96% |
| 3 Month | %th60.50 | 20.42% | -1.98% |
| 12 Month | %th58.50 | 5.16% | -11.92% |
| 5 Years | %th81.50 | 3.33% | -30.30% |
FAQs
Does Teva Pharma Industries (TEVA) outperform the market?
Yes,
over the last 12 months TEVA made 1.13%, while its related Sector, the Health Care Sector SPDR (XLV) made -3.83%.
Over the last 3 months TEVA made 14.55%, while XLV made -4.88%.
Performance Comparison TEVA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
TEVA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.5% | -6.3% | -26.2% | -14% |
| US NASDAQ 100 | QQQ | 0.9% | -6.7% | -27.5% | -13% |
| German DAX 40 | DAX | 1.5% | -0.4% | -39.7% | -28% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.3% | -5.3% | -29.1% | -17% |
| Hongkong Hang Seng | HSI | 1.5% | -7.4% | -44.6% | -34% |
| India NIFTY 50 | INDA | 2.6% | -4.4% | -24.5% | 2% |
| Brasil Bovespa | EWZ | -1.5% | -9.3% | -52.9% | -10% |
TEVA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.2% | -7.6% | -30.9% | -26% |
| Consumer Discretionary | XLY | -0.2% | -4% | -18.3% | -18% |
| Consumer Staples | XLP | 0.2% | -1% | -26.1% | -9% |
| Energy | XLE | 1.2% | -6% | -21% | 3% |
| Financial | XLF | 0% | -5.5% | -30.2% | -29% |
| Health Care | XLV | 1.8% | -3.4% | -18.3% | 5% |
| Industrial | XLI | -0.1% | -5.3% | -33.2% | -23% |
| Materials | XLB | -1.4% | -5.7% | -30.8% | -5% |
| Real Estate | XLRE | 0.7% | -2.3% | -23.9% | -12% |
| Technology | XLK | 0.4% | -9.9% | -29.3% | -10% |
| Utilities | XLU | 1.9% | -1.1% | -27.6% | -22% |
| Aerospace & Defense | XAR | 1.8% | -8.7% | -43.4% | -48% |
| Biotech | XBI | 0.9% | -4.6% | -12.2% | 7% |
| Homebuilder | XHB | -2.4% | -9.6% | -18.3% | -4% |
| Retail | XRT | -2.5% | -5.3% | -21.7% | -10% |
TEVA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.6% | -8.63% | -16.4% | 9% |
| Natural Gas | UNG | 5.3% | 9% | -17.7% | 8% |
| Gold | GLD | 2.6% | -0.5% | -46.1% | -40% |
| Silver | SLV | 2.2% | -7.6% | -44.1% | -19% |
| Copper | CPER | 2.1% | -6.1% | -44.8% | -12% |
TEVA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.5% | -3.7% | -21.7% | 2% |
| iShares High Yield Corp. Bond | HYG | 2.3% | -2.8% | -24.7% | -9% |